Grants and Contributions:
Title:
Development of the eye3 point of contact platform for detecting drugs of abuse
Agreement Number:
1009884
Agreement Value:
$298,500.00
Agreement Date:
Jul 15, 2023 - Dec 31, 2024
Description:
Eye3 is developing a handheld Point of Contact device for the rapid, semi-quantitative detection of drugs of abuse. Eye3’s device is fast, flexible, accurate and easy to use with the ability to detect recent use of THC below levels currently available in the market, in a fraction of the time and at a fraction of the cost
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Burlington, Ontario, CA L7L 1E1
Reference Number:
172-2023-2024-Q2-1009884
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
820205284
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 2 time(s). The total amended value is 48,500 dollars.
Amendment Date
Mar 21, 2024
Recipient's Operating Name:
eye3
Recipient's Legal Name:
eye3concepts Inc.
Federal Riding Name:
Burlington
Federal Riding Number:
35015
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
334512
Amendments: